Banco Bilbao Downgraded to Sell

Tags: bbv
12 Nov 4:55am
Posted by ZacksResearch
0 Comments
Read original blog entry

We are reducing our rating on Banco Bilbao Vizcaya Argentaria, S.A. (or BBVA) (BBV) to Sell from Hold, and cutting our target price to $10 due to the deteriorating economic outlook in Spain. In its third quarter report, BBVA posted net earnings before nonrecurring items of EUR1.4 billion, up 4% from the EUR1.3 billion earned in the comparable 2007 period, but below our estimate due to lower trading revenues and higher-than expected loss provisions.

Results reflected solid growth in net interest income (up 30% year over year), due to higher volumes and improved margins. Noninterest expense rose 14% year over year, while loan loss provisions rose 89%, largely due to growing nonperforming loans.

We are reducing our EPADS estimates to $2.30 from $2.45 for 2008 and to $2.55 from $2.75 for 2009, in part due to changing FX assumptions from recent US$ appreciation against the Euro. We expect recent operating trends to continue near term. We believe the dividend is safe.

Read the analyst note on BBV



Get real-time market insights and profitable stock recommendations from the team of analysts at Zacks Equity Research. See all today’s Analyst Blog entries on Zacks.com.

Comments

Back to top

Post comment

Back to top

Post a comment

Please login to post a comment

About

ZacksResearch

Zacks Investment Research is one of the most highly regarded firms in the investment industry. Our firm has long believed that that quantitative models (like the Zacks Rank) can predict stock prices more accurately than individual analysts. However we also recognize that models are most effective when they are employed by analysts who have deep fundamental knowledge of the company and its industry. Consequently Zacks Equity Research combines Zacks quantitative models with the insight provided by an experienced team of 50 analysts to create superior long term stock recommendations. Discover all their timely insight and recommendations daily on Zacks.com.

Recent Entries